Clinical Trials Logo

Clinical Trial Summary

This ambispective cohort study aims to evaluate the effect of high altitudes environment on human's physiological and metabolic markers, specific markers of main human systems, and incidence rate and severity of chronic mountain sickness (CMS).


Clinical Trial Description

Qinghai-Tibet plateau is a high altitudes area with average 3,000-5,000 meters height in China. As the partial pressure of oxygen in inspired air falls with increasing terrestrial elevation above sea level, many physiological variables in human body could be affected by this hypobaric hypoxic environment. Up to date, there are no large scale clinical trials assessing these changes in chinese population. The study here would like to provide the newest medical information on the changes of physiological variables and correlation between specific risk factors in chinese adults living at high altitudes for work purpose. ;


Study Design


Related Conditions & MeSH terms

  • Altitude Sickness
  • Residence or Prolonged Visit at High Altitude as the Cause of Mountain Sickness

NCT number NCT03446898
Study type Observational
Source Tibetan Traditional Medical College
Contact Tonghua Liu, Professor
Phone +86-13801020306
Email thliu@vip.163.com
Status Recruiting
Phase N/A
Start date July 22, 2017
Completion date July 1, 2019